Targeting DNA repair molecules, such as DNA polymerase β (Pol β), MGMT and N-methylpurine-DNA glycosylase (MPG), increased the sensitivity of cancer cells to alkylating chemotherapeutics [77]. The gene discussed is MPG; the disease is cancer.